Director, Global Biometrics and Data Sciences
Bristol Myers Squibb
Sangwook Choi is based in Seattle, WA and works in the CMC (Chemistry, Manufacturing and Controls) Biostatistics group supporting the Cell Therapy Development and Operations Organization at Bristol Myers Squibb (BMS). He originally joined Juno Therapeutics in 2016 which got acquired by Celgene, and he has worked at BMS since 2019 as a result of the Celgene-BMS integration. Prior to joining BMS, Sangwook had worked at Samsung Electronics and a biotech start-up company. Sangwook holds a Ph.D. in Chemical and Biomolecular Engineering from University of Illinois at Urbana and Champaign, and a Ph.D. from POSTECH in South Korea.